Neurological disorders after zidovudine exposure in utero.
(1) New cases of mitochondrial disorders have been described in French children exposed to zidovudine in utero.  Despite this, zidovudine remains the reference prophylaxis for mother-child HIV transmission.
D005260:Female; D005602:France; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D007231:Infant, Newborn; D019259:Lamivudine / Q000009:adverse effects; D008928:Mitochondria / Q000187:drug effects*; D020258:Neurotoxicity Syndromes; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D012189:Retrospective Studies; D014481:United States; D015215:Zidovudine / Q000009:adverse effects* / Q000627:therapeutic use
D019259:Lamivudine; D015215:Zidovudine